Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals

Blood

Volumn 117, Issue 9, 2011, Pages 2649-2657

  Su, Ruey Chyi ^a   Sivro, Aida ^a   Kimani, Joshua ^b   Jaoko, Walter ^b   Plummer, Francis A ^a,c   Ball, T Blake ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 4; STAT1 PROTEIN;

ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SEXUAL BEHAVIOR;

EID: 79953124454     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-312462     Document Type: Article

References (49)

1. Horton RX, McLaren PX, Fowke K, Kimani J, Ball TX. Cohorts for the study of HIV-1-exposed but uninfected individuals: benefits and limitations. J Infect Dis. 2010;202[suppl 3]:S377-S381.
2. + T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis. 2010;202[suppl 3]:S339-S344.
3. Shearer G, Clerici M. Historical perspective on HIV-exposed seronegative individuals: has nature done the experiment for us? J Infect Dis. 2010;202[suppl 3]:S329-S332.
4. Hladik F, Desbien A, Lang J, et al. Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells. J Immunol. 2003; 171(5):2671-2683. (Pubitemid 37025581)
5. Cohen J. AIDS vaccine research: HIV natural resistance field finally overcomes resistance. Science. 2009;326(5959):1476-1477.
6. Ozato K, Tailor P, Kubota T. The interferon regulatory factor family in host defense: mechanism of action. J Biol Chem. 2007;282(28):20065-20069. (Pubitemid 47099978)
7. Takaoka A, Tamura T, Taniguchi T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 2008; 99(3):467-478. (Pubitemid 351228562)
8. Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res. 2002; 22(1):27-37. (Pubitemid 34161280)
9. Sgarbanti M, Remoli AL, Marsili G, et al. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol. 2008;82(7):3632-3641. (Pubitemid 351429939)
10. Ball TB, Ji H, Kimani J, et al. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS. 2007;21(9):1091-1101. (Pubitemid 46763279)
11. Rein T, Muller M, Zorbas H. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res. 1994; 22(15):3033-3037.
12. Ohmori Y, Schreiber RD, Hamilton TA. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem. 1997;272(23):14899-14907. (Pubitemid 27251761)
13. Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996;348(9038):1347-1351.
14. Su RC, Brown KE, Saaber S, et al. Dynamic assembly of silent chromatin during thymocyte maturation. Nat Genet. 2004;36(5):502-506. (Pubitemid 38620036)
15. Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol. 2009;219(2):243-250.
16. Suganuma T, Workman JL. Crosstalk among histone modifications. Cell. 2008;135(4):604-607.
17. Spivakov M, Fisher AG. Epigenetic signatures of stem-cell identity. Nat Rev Genet. 2007;8(4):263-271. (Pubitemid 46439288)
18. Book MM, Yu-Lee L. Prolactin activation of IRF-1 transcription involves changes in histone acetylation. FEBS Lett. 2001(1);488:91-94. (Pubitemid 32332813)
19. Saha B, Jyothi PS, Chandrasekar B, Nandi D. Gene modulation and immunoregulatory roles of interferon gamma. Cytokine. 2010;50(1):1-14.
20. Norris PJ, Pappalardo BL, Custer B, et al. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses. 2006;22(8):757-762.
21. Rinaldo C, Piazza P, Wang YZ, et al. HIV-1-specific production of IFN-gamma and modulation by recombinant IL-2 during early HIV-1 infection. J Immunol. 1988;140(10):3389-3393.
22. Sakamoto S, Potla R, Larner AC. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon- stimulated early response genes. J Biol Chem. 2004;279(39):40362-40367. (Pubitemid 39287623)
23. Nusinzon I, Horvath CM. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A. 2003;100(25):14742-14747. (Pubitemid 37517961)
24. Klampfer L, Huang J, Swaby LA, Augenlicht L. Requirement of histone deacetylase activity for signaling by STAT1. J Biol Chem. 2004;279(29): 30358-30368. (Pubitemid 38937963)
25. Williams SA, Chen LF, Kwon H, et al. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 2006;25(1):139-149. (Pubitemid 43077303)
26. Kramer OH, Knauer SK, Greiner G, et al. A phosphorylation- acetylation switch regulates STAT1 signaling. Genes Dev. 2009;23(2):223-235.
27. Kaler P, Sasazuki T, Shirasawa S, Augenlicht L, Klampfer L. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity. Exp Cell Res. 2008;314(7):1507-1518.
28. Sgarbanti M, Borsetti A, Moscufo N, et al. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med. 2002;195(10):1359-1370. (Pubitemid 34564337)
29. Ji H, Ball TB, Ao Z, et al. Reduced HIV-1 long terminal repeat transcription in subjects with protective interferon regulatory factor-1 genotype: a potential mechanism mediating resistance to infection by HIV-1. Scand J Infect Dis. 2010;42(5):389-394.
30. Ji H, Ball TB, Kimani J, Plummer FA. Novel interferon regulatory factor-1 polymorphisms in a Kenyan population revealed by complete gene sequencing. J Hum Genet. 2004;49(10):528-535. (Pubitemid 39516981)
31. Beretta A, Furci L, Burastero S, et al. HIV-1- specific immunity in persistently seronegative individuals at high risk for HIV infection. Immunol Lett. 1996;51(1):39-43. (Pubitemid 26227469)
32. Alimonti JB, Kimani J, Matu L, et al. Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya. Immunol Cell Biol. 2006;84(5):482-485.
33. Liu HW, Hong KX, Ma J, et al. Identification of HIV-1 specific T lymphocyte responses in highly exposed persistently seronegative Chinese. Chin Med J (Engl). 2006;119(19):1616-1621. (Pubitemid 44575622)
34. Kaul R, Plummer FA, Kimani J, et al. HIV-1- specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol. 2000;164(3):1602-1611. (Pubitemid 30067280)
35. Kebba A, Kaleebu P, Serwanga J, et al. HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans. AIDS Res Hum Retroviruses. 2004;20(1):67-75. (Pubitemid 38147178)
36. Marsili G, Borsetti A, Sgarbanti M, et al. On the role of interferon regulatory factors in HIV-1 replication. Ann N Y Acad Sci. 2003;1010:29-42. (Pubitemid 38264947)
37. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009;458(7241):1034-1038.
38. Abel K, Rocke DM, Chohan B, Fritts L, Miller CJ. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol. 2005;79(19):12164- 12172. (Pubitemid 41346078)
39. Bosinger SE, Li Q, Gordon SN, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest. 2009;119(12):3556-3572.
40. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest. 2009;119(12):3544-3555.
41. Lee SJ, Jang BC, Lee SW, et al. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS Lett. 2006;580(3):755-762.
42. Boasso A, Shearer GM. How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. Curr Drug Metab. 2007;8(3):217-223. (Pubitemid 46628287)
43. Ozes ON, Taylor MW. Reversal of interferongamma- resistant phenotype by poly(I:C): possible involvement of ISGF2 (IRF1) in interferongamma- mediated induction of the IDO gene. J Interferon Res. 1994;14(1):25-32. (Pubitemid 24288558)
44. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004; 101(16):6062-6067. (Pubitemid 38520528)
45. Penninger JM, Sirard C, Mittrucker HW, et al. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8 thymocytes. Immunity. 1997;7(2):243-254. (Pubitemid 27392016)
46. Penninger JM, Mak TW. Thymocyte selection in Vav and IRF-1 gene-deficient mice. Immunol Rev. 1998;165:149-166. (Pubitemid 28524210)
47. Wang Z, Zang C, Cui K, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009; 138(5):1019-1031.
48. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol. 2001;21(20):7065-7077. (Pubitemid 32916079)
49. Luo Y, Jian W, Stavreva D, et al. Trans-regulation of histone deacetylase activities through acetylation. J Biol Chem. 2009;284(50):34901-34910.